This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cuchel, M. Articles by Rader, D. J. Search for Related Content PubMed PubMed Citation Articles by Cuchel, M. Articles by Rader, D. J.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1710.)
© 2003 American Heart Association, Inc.

Editorials

Genetics of Increased HDL Cholesterol Levels

Insights Into the Relationship Between HDL Metabolism and Atherosclerosis

Marina Cuchel; Daniel J. Rader

From the University of Pennsylvania School of Medicine, Department of Medicine and Center for Experimental Therapeutics. Philadelphia, Pa.

Correspondence to Daniel J. Rader, MD, University of Pennsylvania School of Medicine, 654 BRBII/III Labs, 421 Curie Blvd, Philadelphia, PA 19104. E-mail rader@mail.med.upenn.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Astrong inverse association exists between plasma HDL cholesterol (HDL-C) levels and incidence of coronary artery disease.¹ Although environmental factors play a role, variation in HDL-C levels are at least 50% genetically determined.² The genetics of syndromes of very low HDL-C have been extensively studied. Mutations in apoA-I (the major HDL structural protein), ABCA1 (which promotes efflux of cellular lipids to apoA-I forming nascent HDL particles), and LCAT (which converts unesterified cholesterol to cholesteryl ester [CE] to form the lipid core of mature HDL particles) have all been demonstrated to cause very low levels of HDL-C and apoA-I due to rapid catabolism of apoA-I.³ However, their relationship to premature atherosclerosis is often uncertain, leading to the concept that the HDL-mediated "flux" of cholesterol from the periphery to the liver, where cholesterol is delivered for excretion into the bile (a process known as reverse cholesterol transport [RCT]), may be more important than the actual plasma concentrations of HDL-C in protecting against atherosclerosis.

See page 1869

Syndromes of inherited high HDL-C also exist, but have been much less studied. The only known monogenic cause of inherited high HDL-C in humans is deficiency of the cholesteryl ester transfer protein (CETP), which transfers HDL CE out of HDL to apoB-containing lipoproteins. CETP deficiency results in markedly reduced rates of turnover of apoA-I.⁴ CETP deficiency occurs primarily in Japan, where its relationship to cardiovascular risk is still under debate: some investigators believe it is associated with protection from cardiovascular disease,⁵ whereas others contend that it increases . . . [Full Text of this Article]

This article has been cited by other articles:

				E. M. deGoma, R. L. deGoma, and D. J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211. [Abstract] [Full Text] [PDF]

				M. Cuchel and D. J. Rader Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis? Circulation, May 30, 2006; 113(21): 2548 - 2555. [Full Text] [PDF]

				J. P. Singh, R. Kauffman, W. Bensch, G. Wang, P. McClelland, J. Bean, C. Montrose, N. Mantlo, and A. Wagle Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor {alpha} Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression Mol. Pharmacol., September 1, 2005; 68(3): 763 - 768. [Abstract] [Full Text] [PDF]

				M. A. Tricerri, J. D. Toledo, S. A. Sanchez, T. L. Hazlett, E. Gratton, A. Jonas, and H. A. Garda Visualization and analysis of apolipoprotein A-I interaction with binary phospholipid bilayers J. Lipid Res., April 1, 2005; 46(4): 669 - 678. [Abstract] [Full Text] [PDF]